Results 151 to 160 of about 41,786 (283)
Alzheimer’s disease molecular subtypes in a clinical trial cohort
Abstract Background Alzheimer’s disease (AD) exhibits significant molecular heterogeneity, which poses challenges for treatment development. Understanding this heterogeneity is essential for creating more effective therapies and improving patient outcomes.
Pieter Jelle Visser +6 more
wiley +1 more source
Association between Klotho levels in cerebrospinal fluid and choroid plexus enlargement in neurodegeneration. [PDF]
Sacchi L +15 more
europepmc +1 more source
Sternberg's canal defect: meningitis as the initial presentation in a patient with choroid plexus cyst incidentaloma. Illustrative case. [PDF]
Ayasa LA +8 more
europepmc +1 more source
Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus [PDF]
Jean‐François Ghersi‐Egea +1 more
openalex +1 more source
Abstract Background The glymphatic system’s role in mediating anti‐amyloid therapy efficacy remains underexplored. This study investigates the effects of Lecanemab on glymphatic function, free water distribution, and cognition performance in Alzheimer’s disease.
Ruinan Shen +8 more
wiley +1 more source
Benign yet challenging: a case of adult choroid plexus papilloma. [PDF]
Swain N, Bhawani J.
europepmc +1 more source
ATP7A Gene Addition to the Choroid Plexus Results in Long-term Rescue of the Lethal Copper Transport Defect in a Menkes Disease Mouse Model [PDF]
Anthony Donsante +9 more
openalex +1 more source

